Table 3 Univariable logistic regression analysis for evaluation of the association between risk factors and non-dippers
Factors | Univariable analysis | |
|---|---|---|
Odds ratio (95% Confident Interval) | P value | |
Age | 1.04 (1.02–1.06) | < 0.001 |
Age > 65 years | 3.33 (1.86–5.97) | < 0.001 |
Male | 0.63 (0.36–1.12) | 0.115 |
Bodyweight | 0.98 (0.96–1.00) | 0.069 |
BMI | 0.98 (0.93–1.04) | 0.069 |
Diabetes mellitus | 3.40 (1.67–6.92) | 0.001 |
Dyslipidemia | 2.43 (1.38–4.28) | 0.002 |
Obstructive sleep apnea | 0.87 (0.30–2.48) | 0.789 |
Ischemic stroke | 5.43 (1.16–25.41) | 0.032 |
Coronary artery disease | 1.53 (0.42–5.59) | 0.520 |
Chronic kidney disease | 2.22 (1.06–4.62) | 0.034 |
Diuretics | 0.85 (0.38–1.88) | 0.848 |
CCBs | 1.80 (1.03–3.12) | 0.037 |
ACEIs | 0.87 (0.42–1.81) | 0.708 |
ARBs | 1.31 (0.73–2.35) | 0.372 |
Beta-blockers | 1.89 (1.02–3.52) | 0.045 |
Peripheral alpha-1 blockers | 1.54 (0.68–3.49) | 0.305 |
Central acting alpha-2 agonists | 1.26 (0.33–4.84) | 0.734 |
Direct vasodilators | 0.28 (0.08–1.05) | 0.058 |
Use of > 1 anti-HT medications | 1.39 (0.76–2.52) | 0.287 |
Average office SBP | 1.00 (0.98–1.01) | 0.718 |
Average office DBP | 0.96 (0.93–0.98) | 0.001 |
Hemoglobin | 0.78 (0.66–0.93) | 0.004 |
Hematocrit | 0.92 (0.86–0.98) | 0.006 |
RDW | 1.01 (0.86–1.19) | 0.923 |
MCV | 1.01 (0.98–1.04) | 0.392 |
NLR | 1.10 (0.88–1.37) | 0.405 |
PLR | 1.00 (1.00–1.01) | 0.314 |
Fasting plasma glucose | 1.02 (1.01–1.04) | 0.006 |
Fasting plasma glucose > 5.6 mmol/L | 2.74 (1.56–4.81) | < 0.001 |
HbA1c | 1.40 (0.93–2.11) | 0.112 |
Cholesterol | 0.99 (0.99–1.000) | 0.062 |
Triglyceride | 1.00 (0.99–1.00) | 0.269 |
HDL-cholesterol | 1.01 (0.98–1.02) | 0.558 |
LDL-cholesterol | 0.99 (0.98–1.00) | 0.055 |
Uric acid | 0.87 (0.72–1.04) | 0.129 |
Abnormal proteinuria | 1.37 (0.71–2.64) | 0.346 |
Serum creatinine | 1.19 (0.61–2.32) | 0.620 |
eGFR | 0.98 (0.973–1.00) | 0.009 |